Jeffrey Tyner, Ph.D., assistant professor of Cell, Developmental and Cancer Biology for Oregon Health & Science University, was honored for the development of a research program that more rapidly identifies the mutations driving a patient's cancer and accelerates development of precision treatments.

Lisa Coussens, Ph.D., associate director of basic research for OHSU Knight Cancer Institute, was selected to serve as a principal investigator on an international pancreatic cancer dream team that joins together world-class institutions to study immune system treatments.

Read more about the pancreatic cancer dream team

Joe Gray, Ph.D. talks about understanding the mutations in cancer, key signaling molecules and the pathways involved as well as his vision for the new OHSU Center for Spatial Systems Biomedicine.

Watch our video about understanding the mutations in cancer